Geneseeq at ESMO 2026 in Madrid, Spain

Geneseeq will be exhibiting at ESMO Congress 2026 in Madrid, joining the global oncology community to exchange the latest advances in cancer research, precision medicine, diagnostics, and patient care.

Visit us at Hall 8, Booth 8012B to meet the Geneseeq team, discuss your current programs, and explore opportunities for collaboration across clinical testing, diagnostics, and genomic research.

WHY MEET GENESEEQ AT ESMO 2026?

Whether you are advancing a precision oncology program, developing a biomarker or diagnostic strategy, or exploring new research collaborations, connect with our team to discuss how Geneseeq can support your goals from discovery through clinical application.

• Clinical Testing: Comprehensive genomic profiling solutions supporting precision oncology across diverse tumor types and clinical settings.
• IVD Solutions: Molecular diagnostic products and assay solutions designed for clinically relevant biomarker detection and routine clinical implementation, supported by regulatory pathways across NMPA, FDA, and EU IVDR frameworks.
• Companion Diagnostics: End-to-end CDx development support spanning biomarker strategy, assay development, validation, clinical studies, and regulatory collaboration.
• China Market Access & Commercialization: Leverage Geneseeq’s leading local expertise and capabilities in China to support IVD/CDx development, regulatory strategy, and commercialization for biopharma programs.
• Research & Sequencing Services: NGS and multi-omic services supporting translational research, biomarker discovery, assay development, and clinical studies.